MacroGenics (MGNX) News Today $1.72 -0.09 (-4.97%) Closing price 04:00 PM EasternExtended Trading$1.74 +0.02 (+0.87%) As of 06:41 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock MGNX Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period William Heiden Bought 909% More Shares In MacroGenicsAugust 23, 2025 | finance.yahoo.comWilliam Heiden Bought 909% More Shares In MacroGenicsAugust 23, 2025 | finance.yahoo.comStifel Nicolaus Keeps Their Hold Rating on MacroGenics (MGNX)August 23, 2025 | theglobeandmail.comMacroGenics (NASDAQ:MGNX) Director William Heiden Acquires 49,500 SharesAugust 22, 2025 | insidertrades.comMacroGenics, Inc. (NASDAQ:MGNX) Receives $3.60 Consensus PT from AnalystsAugust 21, 2025 | americanbankingnews.comMacroGenics, Inc. (NASDAQ:MGNX) Receives Average Recommendation of "Moderate Buy" from AnalystsAugust 19, 2025 | marketbeat.comMacroGenics (NASDAQ:MGNX) Given New $5.00 Price Target at Leerink PartnersAugust 18, 2025 | americanbankingnews.comComparing MacroGenics (NASDAQ:MGNX) & Prestige Consumer Healthcare (NYSE:PBH)August 18, 2025 | americanbankingnews.comCitizens JMP Keeps Their Hold Rating on MacroGenics (MGNX)August 17, 2025 | theglobeandmail.comMacroGenics (NASDAQ:MGNX) Posts Quarterly Earnings Results, Beats Estimates By $0.02 EPSAugust 17, 2025 | marketbeat.comLeerink Partners Lowers MacroGenics (NASDAQ:MGNX) Price Target to $5.00August 17, 2025 | marketbeat.comMacroGenics Reports Second Quarter 2025 Financial Results and Highlights Key Strategic PrioritiesAugust 16, 2025 | uk.finance.yahoo.comMacroGenics Revenue Doubles in Q2August 16, 2025 | theglobeandmail.comMacroGenics price target lowered to $5 from $8 at LeerinkAugust 16, 2025 | msn.comMacroGenics (NASDAQ:MGNX) Stock Crosses Below Two Hundred Day Moving Average - Here's WhyAugust 15, 2025 | marketbeat.comMacroGenics Inc. Reports Q2 2025 Financial ResultsAugust 15, 2025 | msn.comMacroGenics reports Q2 EPS (57c), consensus (38c)August 14, 2025 | msn.comMacroGenics Reports Second Quarter 2025 Financial Results and Highlights Key Strategic PrioritiesAugust 14, 2025 | globenewswire.comMacroGenics, Inc.: MacroGenics Appoints Eric Risser as President and Chief Executive OfficerAugust 14, 2025 | finanznachrichten.deMacroGenics Appoints Eric Risser as New CEOAugust 14, 2025 | msn.comMacroGenics CEO Scott Koenig steps down, Eric Risser succeedsAugust 14, 2025 | msn.comMacroGenics Appoints Eric Risser as President and Chief Executive OfficerAugust 13, 2025 | globenewswire.comGSA Capital Partners LLP Raises Position in MacroGenics, Inc. (NASDAQ:MGNX)August 4, 2025 | marketbeat.comMacroGenics (NASDAQ:MGNX) Rating Lowered to "Sell" at Wall Street ZenAugust 3, 2025 | marketbeat.comMacroGenics (MGNX) Projected to Post Earnings on TuesdayJuly 29, 2025 | marketbeat.comMacroGenics Enters Into Agreement With TerSera Therapeutics for the ...July 24, 2025 | businesswire.comMacroGenics, Inc. (NASDAQ:MGNX) Given Average Rating of "Hold" by BrokeragesJuly 24, 2025 | marketbeat.comMacroGenics (NASDAQ:MGNX) Stock Crosses Above Fifty Day Moving Average - Time to Sell?July 22, 2025 | marketbeat.comMacroGenics (NASDAQ:MGNX) Upgraded by Wall Street Zen to "Hold" RatingJuly 12, 2025 | marketbeat.comMacroGenics, Inc. (NASDAQ:MGNX) is largely controlled by institutional shareholders who own 71% of the companyJuly 11, 2025 | finance.yahoo.comMacroGenics (NASDAQ:MGNX) Share Price Crosses Below 200-Day Moving Average - Here's WhyJuly 8, 2025 | marketbeat.comMacroGenics, Inc. (MGNX) Latest Stock News & Headlines - Yahoo Finance CanadaJune 29, 2025 | ca.finance.yahoo.comMacroGenics, Inc. (NASDAQ:MGNX) Given Consensus Rating of "Hold" by AnalystsJune 29, 2025 | marketbeat.comMacroGenics (NASDAQ:MGNX) Stock Rating Lowered by Wall Street ZenJune 27, 2025 | marketbeat.comMacroGenics (NASDAQ:MGNX) Shares Pass Below Two Hundred Day Moving Average - Time to Sell?June 18, 2025 | marketbeat.comMacroGenics’ SWOT analysis: biotech firm’s stock faces pivotal year aheadJune 16, 2025 | investing.comMacroGenics lands $70M 'infusion of cash' to advance clinical programsJune 13, 2025 | bizjournals.comMacroGenics: Working On That Road To RecoveryJune 11, 2025 | seekingalpha.comMacroGenics Shares Rise on Royalty-Purchase AgreementJune 10, 2025 | marketwatch.comMacroGenics Target of Unusually Large Options Trading (NASDAQ:MGNX)June 10, 2025 | marketbeat.comMacroGenics and Sagard Healthcare Partners Enter into ZYNYZ® Royalty Purchase AgreementJune 10, 2025 | globenewswire.comMacroGenics, Inc. (NASDAQ:MGNX) Given Average Recommendation of "Hold" by AnalystsJune 4, 2025 | marketbeat.comMacroGenics to Present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025June 3, 2025 | globenewswire.comMacroGenics (NASDAQ:MGNX) Upgraded to Hold at Wall Street ZenMay 31, 2025 | marketbeat.comMillennium Management LLC Sells 671,179 Shares of MacroGenics, Inc. (NASDAQ:MGNX)May 27, 2025 | marketbeat.comMacroGenics (NASDAQ:MGNX) Lowered to "Sell" Rating by Wall Street ZenMay 24, 2025 | marketbeat.comB. Riley Predicts MacroGenics' Q2 Earnings (NASDAQ:MGNX)May 24, 2025 | marketbeat.comZacks Industry Outlook Highlights Insulet, MacroGenics, Cellectar Biosciences and Allurion TechnologiesMay 23, 2025 | nasdaq.comMacroGenics, Inc. (NASDAQ:MGNX) Holdings Lifted by Frazier Life Sciences Management L.P.May 23, 2025 | marketbeat.comMacroGenics, Inc. (NASDAQ:MGNX) Shares Sold by Vestal Point Capital LPMay 21, 2025 | marketbeat.com Get MacroGenics News Delivered to You Automatically Sign up to receive the latest news and ratings for MGNX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. MGNX Media Mentions By Week MGNX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MGNX News Sentiment▼1.030.97▲Average Medical News Sentiment MGNX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MGNX Articles This Week▼84▲MGNX Articles Average Week Get the Latest News and Ratings for MGNX and Related Stocks Enter your email address to receive the latest news and analysts' ratings for MacroGenics and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Compass Therapeutics News I-Mab News Corvus Pharmaceuticals News Kamada News Aura Biosciences News Aquestive Therapeutics News Olema Pharmaceuticals News Rocket Pharmaceuticals News Y-mAbs Therapeutics News Vigil Neuroscience News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MGNX) was last updated on 8/27/2025 by MarketBeat.com Staff From Our PartnersMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MacroGenics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MacroGenics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access